These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39425791)

  • 1. Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy.
    Toto L; Ares I; Quarta A; Viggiano P; Ruggeri M; Formenti F; Boscia G; Porreca A; Di Nicola M; Boscia F; Mastropasqua R
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; ():. PubMed ID: 39425791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Half-Dose Photodynamic Therapy with Subthreshold Micropulse Laser for the Treatment of Central Serous Chorioretinopathy.
    Brelen ME; Ho M; Li S; Ng DSC; Yip YWY; Lee WS; Chen LJ; Young AL; Tham CC; Pang CP
    Ophthalmol Retina; 2024 May; 8(5):490-498. PubMed ID: 37956794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossover to PDT after the unsuccessful micropulse laser treatment of central serous chorioretinopathy.
    Gawęcki M; Kiciński K; Grzybowski A
    Adv Ophthalmol Pract Res; 2024; 4(1):32-38. PubMed ID: 38406665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
    Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
    Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy.
    Ntomoka CG; Rajesh B; Muriithi GM; Goud A; Chhablani J
    Eye (Lond); 2018 Jun; 32(6):1079-1086. PubMed ID: 29429986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and anatomical results of subthreshold micropulse laser as rescue treatment for central serous chorioretinopathy after verteporfin shortage.
    Oribio-Quinto C; Alarcón-Garcia AD; Enriquez-Fuentes J; Burgos-Blasco B; Fernandez-Vigo JI
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104295. PubMed ID: 39067672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
    van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Dijkman G; Peters PJH; Tsonaka R; Keunen JEE; MacLaren RE; Hoyng CB; Downes SM; Fauser S; Boon CJF
    Acta Ophthalmol; 2021 Nov; 99(7):805-811. PubMed ID: 33565230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy.
    Zheng F; He J; Su Z; Liu Y; Xu Y; Liu L; Ye P
    BMC Ophthalmol; 2022 Jun; 22(1):252. PubMed ID: 35668416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the subthreshold micropulse yellow wavelength laser photostimulation in the treatment of chronic central serous chorioretinopathy.
    Işık MU; Değirmenci MFK; Sağlık A
    Int J Ophthalmol; 2020; 13(9):1404-1410. PubMed ID: 32953579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
    Hua L; Lin B; Hong J; Min HB; Han WL; Zhou TY; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):278-284. PubMed ID: 29424884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy.
    van Rijssen TJ; Singh SR; van Dijk EHC; Rasheed MA; Vupparaboina KK; Boon CJF; Chhablani J
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1191-1197. PubMed ID: 32170365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Altinel MG; Kanra AY; Totuk OMG; Ardagil A; Turkmen OF
    J Fr Ophtalmol; 2021 Apr; 44(4):499-508. PubMed ID: 33642060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Cheng CK; Chang CK; Peng CH
    Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthreshold Micropulse Treatment Laser versus Half-Dose Photo Dynamic Therapy for the Chronic Central Serous Chorioretinopathy with Parafoveal or Subfoveal Leakage STML versus PDT for Treatment of Chronic CSC.
    Chen Q; Zhao X; Yin Q; Li Z; Zhao Z; Ning J
    J Ophthalmol; 2022; 2022():3627903. PubMed ID: 35814483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study.
    Romano MR; Parolini B; Allegrini D; Michalewska Z; Adelman R; Bonovas S; Bopp S;
    Acta Ophthalmol; 2020 Aug; 98(5):e549-e558. PubMed ID: 31808315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy.
    Zeng M; Chen X; Song Y; Cai C
    BMC Ophthalmol; 2022 Mar; 22(1):110. PubMed ID: 35260118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study.
    Iovino C; Au A; Chhablani J; Parameswarappa DC; Rasheed MA; Cennamo G; Cennamo G; Montorio D; Ho AC; Xu D; Querques G; Borrelli E; Sacconi R; Pichi F; Woodstock E; Sadda SR; Corradetti G; Boon CJF; van Dijk EHC; Loewenstein A; Zur D; Yoshimi S; Freund KB; Peiretti E; Sarraf D
    Am J Ophthalmol; 2020 Sep; 217():104-113. PubMed ID: 32360342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short term choroidal microvascular changes following photodynamic therapy in chronic central serous chorioretinopathy.
    Bazvand F; Asadigandomani H; Nezameslami A; Sadeghi R; Soleymanzadeh M; Khodabande A; Riazi-Esfahani H
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103807. PubMed ID: 37734563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.
    Hayashida M; Miki A; Honda S; Nakamura M
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101955. PubMed ID: 32818640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.